ARTICLE | Financial News
Corixa falls on Bexxar news
January 10, 2002 8:00 AM UTC
CRXA was off $2.39 (16%) to $12.38 on 3.4 million shares on Thursday. On Wednesday after market close, CRXA said the FDA's Oncologic Drugs Advisory Committee (ODAC) will not review the company's BLA f...